| Application no. and date | 15735733.6 (espacenet) (Federated) (European Patent Register), 20150408 | | Patent/reg. no. and date | DK/EP 3129006, 20210127 | | Publication date | 20170215 | | Priority no. and date | US 201461977806 P, 20140410 | | EP pub. no. and date |
EP 3129006 20170215 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | BT/GP/163886 | | Inventor | BOUILLOT, Philippe Michel Rene, c/o Novartis Pharma AG
Postfach
4002 Basel, CH,
REYNAUD, Emeric, c/o Novartis Pharma AG
Postfach
4002 Basel, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/397 (2006.01) , A61K 9/16 (2006.01) , A61K 9/20 (2006.01) , A61K 9/28 (2006.01) | | Title | Immunsupprimerende formulering | | Int. application no. | IB2015052552 | | Int. publication no. | WO2015155711 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
